Emerging Markets And Digital Health Will Fuel Future Expansion

Published
17 Jul 24
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
US$887.60
19.8% undervalued intrinsic discount
20 Aug
US$711.68
Loading
1Y
-25.3%
7D
1.5%

Author's Valuation

US$887.6

19.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Decreased 18%

Shared on30 Apr 25
Fair value Decreased 1.51%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 0.025%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Decreased 0.26%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.099%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 8.97%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 0.38%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 5.68%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.